New Treatment Option for Severe Asthma and Nasal Polyps Approved in Europe
A new medicine called Exdensur (depemokimab) has been approved in Europe for two conditions: severe asthma with type 2 inflammation […]
A new medicine called Exdensur (depemokimab) has been approved in Europe for two conditions: severe asthma with type 2 inflammation […]
As a pharmacist, I’d like to share some recent news in the pharmaceutical industry and explain it in simple terms.
An Atlanta-based biotechnology company called Altesa BioSciences recently announced that it has raised $75 million to further develop a drug
Valneva, a company specializing in travel vaccines, saw a decrease in product sales in 2025 due to market restrictions on
Lario Therapeutics, a company based in Edinburgh, has received $2.4 million in new funding from The Michael J Fox Foundation
A recent study has found that understanding how pills break and how soft or hard they are could help us
Madrigal Pharmaceuticals, the first company to get U.S. approval for a medicine treating the common liver disease MASH, is now
Big drug companies are working hard to make cancer treatments called CAR-T cell therapies more accessible. These treatments have been
In 2026, Novartis is making progress in getting full approval for their drug Vanrafia to treat IgA nephropathy, a type
Sanofi, a big French drug company, has a new CEO. Paul Hudson is stepping down after six years. During his